SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies

Abroad (travel likely)RecruitingPHASE2

Conditions

Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Shun Lu, MD)
Contact: Principal Investigator (Jian Zhou, MD)

Study leads

Shun Lu, MD
Principal Investigator
Shanghai Chest Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

Aplastic Anemia

Abroad (travel likely)RecruitingPHASE2

Paris, France · Amiens, France

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Severe Aplastic Anemia

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

Primary Immune Deficiency Disorder · Immune Deficiency Disease · Bone Marrow Failure

Abroad (travel likely)RecruitingPHASE2

Baltimore, United States

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

Refractory Idiopathic Aplastic Anemia · Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Abroad (travel likely)RecruitingPHASE2

Amiens, France · Angers, France